Hester Biosciences Limited (BOM:524669)
India · Delayed Price · Currency is INR 1,954.35
-67.80 (-3.35%)
At close: Jun 3, 2026
Hester Biosciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 16,625 | 10,741 | 10,667 | 11,818 | 12,934 | 23,099 | |
Market Cap Growth | 10.46% | 0.70% | -9.74% | -8.63% | -44.00% | 41.66% |
Enterprise Value | 18,583 | 12,929 | 13,063 | 14,503 | 15,490 | 24,167 |
Last Close Price | 1954.35 | 1262.65 | 1249.57 | 1381.11 | 1504.56 | 2675.03 |
PE Ratio | 28.92 | 19.31 | 38.81 | 62.57 | 48.58 | 58.75 |
PS Ratio | 5.00 | 3.23 | 3.41 | 3.80 | 4.65 | 9.37 |
PB Ratio | 4.52 | 2.92 | 3.27 | 3.90 | 4.48 | 8.64 |
P/TBV Ratio | 4.74 | 3.06 | 3.47 | 4.11 | 4.67 | 8.96 |
P/FCF Ratio | 35.90 | 23.19 | 24.29 | 49.69 | - | - |
P/OCF Ratio | 25.92 | 16.75 | 16.54 | 24.53 | 54.82 | 265.14 |
EV/Sales Ratio | 5.59 | 3.89 | 4.18 | 4.66 | 5.57 | 9.80 |
EV/EBITDA Ratio | 19.98 | 14.92 | 21.06 | 24.17 | 24.81 | 33.90 |
EV/EBIT Ratio | 25.06 | 19.08 | 28.63 | 33.63 | 36.86 | 43.91 |
EV/FCF Ratio | 40.13 | 27.92 | 29.74 | 60.97 | - | - |
Debt / Equity Ratio | 0.53 | 0.53 | 0.69 | 0.85 | 0.95 | 0.85 |
Debt / EBITDA Ratio | 2.25 | 2.25 | 3.59 | 4.28 | 4.38 | 3.19 |
Debt / FCF Ratio | 4.21 | 4.21 | 5.09 | 10.84 | - | - |
Net Debt / Equity Ratio | 0.51 | 0.51 | 0.66 | 0.80 | 0.90 | 0.76 |
Net Debt / EBITDA Ratio | 2.17 | 2.17 | 3.49 | 4.04 | 4.16 | 2.85 |
Net Debt / FCF Ratio | 4.07 | 4.07 | 4.93 | 10.19 | -4.79 | -2.33 |
Asset Turnover | 0.50 | 0.50 | 0.48 | 0.47 | 0.45 | 0.51 |
Inventory Turnover | 1.15 | 1.15 | 1.27 | 1.24 | 1.03 | 0.99 |
Quick Ratio | 0.67 | 0.67 | 0.70 | 0.95 | 0.68 | 0.85 |
Current Ratio | 1.37 | 1.37 | 1.56 | 2.04 | 1.53 | 2.01 |
Return on Equity (ROE) | 16.55% | 16.55% | 9.16% | 7.16% | 10.09% | 15.69% |
Return on Assets (ROA) | 6.36% | 6.36% | 4.33% | 4.05% | 4.26% | 7.07% |
Return on Invested Capital (ROIC) | 9.23% | 9.35% | 6.11% | 5.23% | 5.76% | 10.22% |
Return on Capital Employed (ROCE) | 12.90% | 12.90% | 8.60% | 7.70% | 8.10% | 11.80% |
Earnings Yield | 3.35% | 5.18% | 2.58% | 1.60% | 2.06% | 1.70% |
FCF Yield | 2.79% | 4.31% | 4.12% | 2.01% | -4.19% | -3.77% |
Dividend Yield | 0.54% | 0.87% | 0.56% | 0.43% | 0.53% | 0.37% |
Payout Ratio | 10.83% | 10.83% | 18.80% | 36.28% | 31.95% | 21.63% |
Buyback Yield / Dilution | 3.20% | 3.20% | - | - | - | - |
Total Shareholder Return | 3.75% | 4.08% | 0.56% | 0.43% | 0.53% | 0.37% |